
A physical method for putting molecules inside cells. Cells flow through a microfluidic constriction that briefly opens pores in the membrane, cargo diffuses in, and the membrane reseals within seconds — no electrical pulse, no viral vector, no lipid carrier.
Portal Bio builds the instruments and consumables that make mechanoporation practical from the research bench to clinical GMP, across a broad range of cell types and cargos, with near-zero transcriptional disruption.
Method | How it works | Cargos it handles | Effect on the cell | Practical limit |
Electroporation | Brief electric pulse permeabilizes the membrane. | Most cargo classes. | Wide transcriptional disruption (330+ misregulated genes at q<0.05). Reduced viability and proliferation. | Often requires cell pre-activation to survive the pulse. |
Lipofection / LNPs | Lipid carrier shuttles cargo across the membrane via endocytosis. | Mostly RNA and DNA. | Variable cell-type response; lipid- and endocytosis-dependent toxicity. | Not a route for proteins, RNPs, or small molecules. |
Viral vectors (AAV, lentivirus) | Capsid binds the cell and delivers a packaged genome. | Genes, within a size limit. | Immunogenic; risk of integration or unwanted persistence. | Slow and expensive to produce; cargo size capped. |
Mechanoporation | Cells flow through a constriction; transient pores form by mechanical deformation. | Any cargo class — proteins, RNPs, mRNA, small molecules, DELs, etc. | Effectively no transcriptional disruption (0 misregulated genes at q<0.05). | Cartridge selected per cell type. |
Simultaneous CRISPR RNP, mRNA, and dextran delivered to T cells in a single step (0% in control).
High-throughput, arrayed CRISPR editing across a full 96-well plate (~100 automated dispenses) in primary human T cells.
Mechanoporation leaves the transcriptional state intact: 0 misregulated genes at q<0.05 versus 330+ for electroporation (DiTommaso 2018).
Mechanoporation is one platform that handles cells and payloads other methods can't. If yours isn't listed, we run feasibility studies.

Sophia M. Hirsch, Darby Kreienberg, Zhihui Song, Andrew Larocque, Yi Zuo, Rachel Conover, Eleni Jaecklein, Karen Gonzalez, Ain Imchen, Sean Franco, Michael A. Evans, R. Alexander Wesselhoeft, Matthew R. Swiatnicki, Hicham Zegzouti, Kirill Chesnov, Marius Wernig, Neil S. Dhawan, Cameron Pye, Scott M. Loughhead, Jacquelyn L. Sikora Hanson, Alec Barclay, Armon Sharei